<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00952770</url>
  </required_header>
  <id_info>
    <org_study_id>CNUH-09-07-60</org_study_id>
    <nct_id>NCT00952770</nct_id>
  </id_info>
  <brief_title>Effect of Statins on the Radial Intima-media Thickness After Transradial Angioplasty</brief_title>
  <official_title>Effect of Statins on the Progression of the Intima-media Thickness of the Radial Artery After Radial Angioplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chungnam National University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chungnam National University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The first event of the atherosclerotic plaque formation is the accumulation of the low
      density lipoprotein-cholesterol (LDL-cholesterol) in to the intima of the arterial wall.
      After accumulation of the LDL-cholesterol, the oxidation of the LDL-cholesterol particles and
      recruitment of monocytes to the intima and media are the next steps. The thickening of
      intima-media thickness (IMT) is resulted from these initial events. The IMT can be easily
      measured by high-resolution ultrasonography in various arteries including carotid, brachial
      and radial arteries. The increased carotid IMT can be used as a non-invasive independent
      parameter indicating increased cardiovascular mortality. Some investigators reported
      increased radial IMT is associated with increased early failure of the radiocephalic
      arteriovenous fistula in the hemodialysis patients. Moreover, radial IMT is increased in
      patients underwent radial artery intervention because of denudation injury of the radial
      artery. Recently, the use of statin can halt the progression of the carotid IMT progression.
      However, it is unknown that the use of statin can prevent the progression of radial IMT after
      the transradial coronary intervention. The investigators want to evaluate the effect of
      statins on the progression of the radial IMT after the transradial intervention.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2009</start_date>
  <primary_completion_date type="Anticipated">July 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference of IMT between two groups</measure>
    <time_frame>1 month, 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference of epicardial fat thickness Difference of cholesterol level</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Atorvastatin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group receiving atorvastatin 20mg/day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Simvastatin/Ezetimibe</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group receiving simvastatin/ezetimibe 10/10mg</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>transradial coronary intervention</intervention_name>
    <description>percutaneous coronary intervention with transradial approach</description>
    <arm_group_label>Atorvastatin</arm_group_label>
    <arm_group_label>Simvastatin/Ezetimibe</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing coronary intervention via the radial artery

        Exclusion Criteria:

          -  Contraindication to statins

          -  Left ventricular ejection fraction less than 30%

          -  Recent history of hematologic disease or leukocyte count &lt;3000/mm3 and/or platelet
             &lt;100 000/mm3

          -  Hepatic dysfunction with AST or ALT &gt;3 times the upper normal reference limit

          -  History of renal dysfunction or a serum creatinine level &gt;2.0 mg/dL

          -  Serious noncardiac comorbid disease with a life expectancy &lt;1 year

          -  Inability to follow the protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jae-Hyeong Park, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chungnam National University, Chungnam National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jae-Hyeong Park, MD, PhD</last_name>
    <phone>82-42-280-7167</phone>
    <email>jaehpark@cnuh.co.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Si Wan Choi, MD, PhD</last_name>
    <phone>82-42-280-8237</phone>
    <email>csw1967@cnuh.co.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chungnam National University Hospital</name>
      <address>
        <city>Daejeon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jae-Hyeong Park, MD, PhD</last_name>
      <phone>82-42-280-7167</phone>
      <email>jaehpark@cnuh.co.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 4, 2009</study_first_submitted>
  <study_first_submitted_qc>August 4, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2009</study_first_posted>
  <last_update_submitted>August 4, 2009</last_update_submitted>
  <last_update_submitted_qc>August 4, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 6, 2009</last_update_posted>
  <responsible_party>
    <name_title>Jae-Hyeong Park, MD, PhD</name_title>
    <organization>Chungnam National University, Chungnam National University Hospital</organization>
  </responsible_party>
  <keyword>Coronary artery disease</keyword>
  <keyword>Coronary intervention</keyword>
  <keyword>intima-media thickness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>July 29, 2013</submitted>
    <returned>September 26, 2013</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

